Afuco™ Anti-Human ACVR2A ADCC Therapeutic Antibody, ADCC Enhanced
Anti-ACVR2A ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Molecules having activin or ActRIIa antagonist activity ("activin antagonists" and "ActRIIa antagonists") can be used to increase bone density, promote bone growth, and/or increase bone strength.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-010CL |
Pricing | Inquiry |
Host | Mouse |
Target | ACVR2A |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Storage | ≤1 year at -20°C. |